BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY Conditional Marketing Authorization to Full Marketing Authorization in the European Union
Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY Original/Omicron BA.4-5 and COMIRNATY Original/Omicron BA.1 bivalent
Source: finanznachrichten.de